Board of Directors

Thomas D. Follett

Mr. Follett serves as chair of the board of directors.  He is a graduate from Norte Dame University (BSE), University of Michigan (MSE) and Xavier University (MBA).   He was an engineer with GE designing aircraft engines.  In 1975, he joined Arthur Andersen which evolved into Accenture.  Mr. Follett became a partner in Accenture in 1985 and specialized in manufacturing systems design and installation in high tech industry.  He retired in 2000 after 25 years with Accenture.  Mr. Follett’s other civic work includes serving on the That Man May See as Chair of the Clinic Committee and is a past president of the ALS Association Bay Area Chapter.

Carrolee Barlow, MD, PhD
Chief Executive Officer

Dr. Barlow received her MD from the University of Utah, did a residency in Internal Medicine at The New York Hospital, Cornell Medical Center and a PhD in molecular and developmental biology at the Karrolinska Medical Nobel Institute in Stockholm, Sweden.  She joined the National Institutes of Health and completed medical subspecialty training in the field of endocrinology and a postdoctoral fellowship in neurogenetics at the National Human Genome Research Institute.  She was a faculty member of the Salk Institute in  translational medicine and genetics.  She has been a pharmaceutical executive since 2002, serving as Chief Scientific Officer and Chief Medical Officer of BrainCells, Inc.  Prior to BrainCells, she served as the Director of Molecular Neuroscience and Therapeutic Area Head for Stroke and Neurodegeneration at Merck Research Laboratories.  Her work has been published in many research journals.  

Peter C. Nosler
Vice Chair

Mr. Nosler is known for his collaborative approach to business leadership.  He and two partners started DPR Construction in 1990 and quickly transformed it from one of the fastest growing private companies in the region to one frequently named among the Best Places to Work.  Today, DPR is one of Silicon Valley’s biggest contractors with a client list that includes AT&T, Apple Computer, and Charles Schwab & Co.  Based in Redwood City, DPR focuses on projects for the biotech, pharmaceutical, and semiconductor markets. The employee-owned company completes about 125 major projects per year.  Over the last ten years DPR has been ranked in the top 50 general contractors in the country, has surpassed the billion dollar mark in sales, and has more than 2000 employees nationwide.  Mr. Nosler leads the DPR Foundation and is an active volunteer with the Monterey Bay Aquarium. 

Susan J. Foster

Ms. Foster is a graduate of University of Nebraska (BA) and San Jose State Univeristy (MA).  She is a former Registered Nurse (RN).  She is a Partner with Learning Designs, Inc.  She has served as a marketing director with Alza Pharmaceuticals.   Her civic engagement includes The Stem Cell Advisors, Child Development Inc. and St. Francis High School. 

Ari Chaney, MBA
Board Member

Mr. Chaney has an MBA from the University of Chicago with High Honors, and a BS in Electrical Engineering from Worcester Polytechnic Institute with High Distinction. Most recently, he was the co-founder and CFO of Cellular Research, a genomics company developing a disruptive platform for precision biology research that was acquired by Becton Dickinson in 2015. Prior to building Cellular Research, Mr. Chaney was the Executive Director for Technology Translation for the Biodesign Program at Stanford University. Mr. Chaney is also the President and Founder of Leveraged Restructuring, where he has held Chairman or CEO positions with a number of companies including: Neucel Specialty Cellulose, Monona Wire Corporation, Rapid Rack Industries and Bomar Industries. Earlier in his career he served as Vice President, Supply Chain for Florida Power & Light (FPL), President and CEO of Aladdin Industries and within General Electric, President & GM of Midwest Electric, Plant Manager of the Austintown Products Plant in GE Lighting, and Manager of Corporate Business Development in GE Corporate. He currently serves on the Boards of Stealth Biosciences, 13.8, and The Parkinson’s Institute.

Sheldon Englehorn
Board Member

Sheldon is an entrepreneur who co-founded a life sciences tool company (now part of Thermo Fisher Scientific). He has served as an Alumni  regent of the University of California, and a trustee of the UC San Diego Foundation. An avid surfer, Sheldon is active with the Director’s Cabinet at Scripps Institution of Oceanography and received the Chancellor’s Medal in 2011.  He also serves as a board member of Nature and Culture International - a conservation organization founded by fellow P.I. director, Ivan Gaylor.

Ivan Gayler
Board Observer

Mr. Gayler is a long time real estate developer and founder of Del Mar Partnership.  Mr. Gayler founded Nature and Culture International in 1997.  Nature and Culture International has helped conserve 8.7 million acres of threated habitats in South America.  His work has been recognized with the San Diego Zoo’s Conservation Medal, an honor shared with Jane Goodall and David Attenborough.  

Judith A. Hemberger, PhD, MBA
Board Member

Dr. Hemberger received her PhD in Pharmacology form the University of Missouri, MBA from Rockhurst College and BS from Mount St. Scholastica College. She is the President and CEO of Suvica, a start-up biotech company. She has been a venture partner with Normura Phase 4 Ventures, Interim CEO of Zosano Pharma and Co-Founder, Executive Vice-President and COO, of Pharmion Corporation which was acquired by Celgene in 2008 for $2.7 billon.

Vernon Norviel, J.D.
Board Member

Mr. Norviel is a partner at Wilson Sonsini Goodrich & Rosati, where he leads the patents and innovation counseling practice. Mr. Norviel has three decades of experience in formulating successful strategies for life science companies and the development of their IP programs. He represents a wide variety of companies, as well as venture capital firms, in areas such as therapeutics, diagnostics, nanotechnology, genomics, proteomics, and personalized medicine. In fact, Mr. Norviel's interest in the field of personalized medicine prompted him to become the first attorney to have had his or her entire genome sequenced and made available in a public database. Before joining the firm in 2003, Mr. Norviel was the general counsel and corporate secretary of Perlegen Sciences, Inc., a start-up biotechnology company that scans the entire human genome for important therapeutic and diagnostic products. Previously, as senior vice president and general counsel, he was an early employee of Affymetrix, the biotechnology company that pioneered and developed DNA chip technology. He also had been a partner at Townsend and Townsend and Crew in Palo Alto.Mr. Norviel currently serves as a member of Wilson Sonsini Goodrich & Rosati's Compensation Committee and on the board of the WSGR Foundation, and previously served as a member of the Policy Committee. In addition, he is a lecturer in biotechnology law at UC Berkeley School of Law.

Michael Saign
Board Member

Michael Saign is a Senior Managing Director in Newmark Cornish & Carey’s Silicon Valley office and has consistently been one of the top ranked advisors within the firm. Mr. Saign specializes in developing and implementing customized real estate strategies for a diverse group of clients ranging from high growth startup ventures to global Fortune 500 corporations. In 2015, he directly managed the successful completion of over 1,000,000 square feet of transactions and was ranked within the Top 5 of all Newmark Cornish & Carey agents. Since joining the firm, Mr. Saign has completed over 275 assignments advising technology, life science and professional service companies
Mr. Saign is a native of Silicon Valley and graduate of Boston College where he rowed on the crew team. He currently serves on the Parkinson’s Institute and Clinical Center’s board of directors.

2500 Hospital Drive, Bldg #10, Suite 1 | Mountain View, CA 94040
650.770.0201 main | 650.770.0204 fax (Clinic Secure)